Yufei Lu

1.0k total citations
55 papers, 662 citations indexed

About

Yufei Lu is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yufei Lu has authored 55 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yufei Lu's work include Spine and Intervertebral Disc Pathology (4 papers), Esophageal Cancer Research and Treatment (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Yufei Lu is often cited by papers focused on Spine and Intervertebral Disc Pathology (4 papers), Esophageal Cancer Research and Treatment (4 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Yufei Lu collaborates with scholars based in China, United States and Hong Kong. Yufei Lu's co-authors include Chengliang Yang, Xiaoli Zheng, Ke Ye, Hong Ge, Leiming Guo, Yanan Sun, Hong Ge, Tianhang Xie, Lan Ma and Sining Shen and has published in prestigious journals such as Circulation Research, Water Research and The FASEB Journal.

In The Last Decade

Yufei Lu

50 papers receiving 651 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yufei Lu China 15 249 170 123 100 90 55 662
Hua Yan China 17 298 1.2× 149 0.9× 46 0.4× 29 0.3× 119 1.3× 58 780
Xin Jing China 11 222 0.9× 50 0.3× 100 0.8× 91 0.9× 70 0.8× 60 695
Sundaravadivel Balasubramanian United States 18 411 1.7× 82 0.5× 69 0.6× 39 0.4× 46 0.5× 33 783
Michelle Tang United States 12 334 1.3× 99 0.6× 42 0.3× 45 0.5× 44 0.5× 20 846
Zhiping Zhao China 18 348 1.4× 202 1.2× 114 0.9× 24 0.2× 86 1.0× 37 816
Fahad Mahmood United Kingdom 13 185 0.7× 97 0.6× 138 1.1× 42 0.4× 80 0.9× 40 640
Shaodan Zhang China 17 386 1.6× 210 1.2× 35 0.3× 66 0.7× 83 0.9× 65 920
Fen Wang China 18 432 1.7× 165 1.0× 109 0.9× 39 0.4× 131 1.5× 52 1.0k
Qisheng Tang China 20 395 1.6× 152 0.9× 120 1.0× 51 0.5× 76 0.8× 77 967
Xiaowei Guo China 18 509 2.0× 159 0.9× 135 1.1× 19 0.2× 58 0.6× 55 886

Countries citing papers authored by Yufei Lu

Since Specialization
Citations

This map shows the geographic impact of Yufei Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yufei Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yufei Lu more than expected).

Fields of papers citing papers by Yufei Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yufei Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yufei Lu. The network helps show where Yufei Lu may publish in the future.

Co-authorship network of co-authors of Yufei Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yufei Lu. A scholar is included among the top collaborators of Yufei Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yufei Lu. Yufei Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yingxue, Shi Jin, Jun Chen, et al.. (2025). Cordycepin Ameliorates Renal Interstitial Fibrosis by Inhibiting Drp1-Mediated Mitochondrial Fission. Drug Design Development and Therapy. Volume 19. 1271–1287. 2 indexed citations
2.
3.
Lu, Yufei & Zhao Fu. (2025). Strategies to overcome tumour relapse caused by antigen escape after CAR T therapy. Molecular Cancer. 24(1). 126–126. 7 indexed citations
4.
Shi, Yiqin, Nana Song, Shuan Zhao, et al.. (2024). Associations between metabolic profiles and incident CKD in the Chinese population aged 45–85 years. International Urology and Nephrology. 56(7). 2325–2336. 3 indexed citations
7.
Lu, Junmi, Yufei Lu, Shuguang Yuan, et al.. (2023). CD4+ T-Cell Legumain Deficiency Attenuates Hypertensive Damage via Preservation of TRAF6. Circulation Research. 134(1). 9–29. 12 indexed citations
8.
Raffetseder, Ute, Bowen Zhu, Jing Chen, et al.. (2023). Association Between High NK-Cell Count and Remission of Primary Membranous Nephropathy: A Retrospective Chart Review and Pilot Study. Clinical Therapeutics. 45(4). 364–374. 1 indexed citations
9.
Lu, Yufei, Yichun Ning, Yang Li, et al.. (2023). Risk factor mining and prediction of urine protein progression in chronic kidney disease: a machine learning- based study. BMC Medical Informatics and Decision Making. 23(1). 173–173. 4 indexed citations
10.
Liu, Denghui, Yufei Lu, Yi Wu, et al.. (2023). Solution-processable thermally activated delayed fluorescence red emitters poly(carbazole-fluorene) containing naphthalene imide units. Polymer. 285. 126316–126316. 4 indexed citations
11.
Hao, Jing, Na Zhang, Yahua Zhong, et al.. (2022). Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL Trial. Practical Radiation Oncology. 12(5). 397–408. 5 indexed citations
12.
Xie, Tianhang, Long Zhao, Yufei Lu, et al.. (2022). Influence of coronal-morphology of endplate and intervertebral space to cage subsidence and fusion following oblique lumbar interbody fusion. BMC Musculoskeletal Disorders. 23(1). 633–633. 13 indexed citations
13.
Zhao, Long, et al.. (2022). Clinical and radiological evaluation of cage subsidence following oblique lumbar interbody fusion combined with anterolateral fixation. BMC Musculoskeletal Disorders. 23(1). 214–214. 44 indexed citations
14.
Li, Yue, Yufei Lu, Yun Zhou, et al.. (2021). Diurnal transcriptomics analysis reveals the regulatory role of the circadian rhythm in super-hybrid rice LY2186. Genomics. 113(3). 1281–1290. 6 indexed citations
15.
Chen, Chaochao, Jin Tan, Yufei Lu, et al.. (2020). A Hybrid-Domain Framework for Secure Gradient Tree Boosting.. arXiv (Cornell University). 10 indexed citations
16.
He, Yuhu, Yufei Lu, Daile Jia, et al.. (2020). Osteoprotegerin promotes intimal hyperplasia and contributes to in-stent restenosis: Role of an αVβ3/FAK dependent YAP pathway. Journal of Molecular and Cellular Cardiology. 139. 1–13. 15 indexed citations
17.
Yang, Chengliang, Sining Shen, Xiaoli Zheng, et al.. (2019). Long noncoding RNA HAGLR acts as a microRNA‐143‐5p sponge to regulate epithelial‐mesenchymal transition and metastatic potential in esophageal cancer by regulating LAMP3. The FASEB Journal. 33(9). 10490–10504. 45 indexed citations
18.
Yang, Chengliang, Xiaoli Zheng, Ke Ye, et al.. (2018). NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway. The International Journal of Biochemistry & Cell Biology. 99. 43–51. 20 indexed citations
19.
Yang, Chengliang, Xiaoli Zheng, Ke Ye, et al.. (2018). MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1. Cellular Physiology and Biochemistry. 46(1). 93–106. 37 indexed citations
20.
Sun, Yanan, Yufei Lu, Wei Guo, et al.. (2014). Interfractional Variations of Tumor Centroid Position and Tumor Regression during Stereotactic Body Radiotherapy for Lung Tumor. BioMed Research International. 2014. 1–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026